Louisiana State Employees Retirement System Acquires Shares of 92,400 Hims & Hers Health, Inc. (NYSE:HIMS)

Louisiana State Employees Retirement System acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 92,400 shares of the company’s stock, valued at approximately $2,234,000.

A number of other large investors have also recently added to or reduced their stakes in HIMS. CWM LLC boosted its stake in Hims & Hers Health by 21.4% during the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock valued at $110,000 after acquiring an additional 1,054 shares during the last quarter. Creative Planning boosted its stake in Hims & Hers Health by 18.1% during the 3rd quarter. Creative Planning now owns 25,925 shares of the company’s stock valued at $478,000 after acquiring an additional 3,979 shares during the last quarter. nVerses Capital LLC lifted its position in shares of Hims & Hers Health by 31.8% in the 3rd quarter. nVerses Capital LLC now owns 14,100 shares of the company’s stock worth $260,000 after buying an additional 3,400 shares during the last quarter. Cadent Capital Advisors LLC bought a new position in shares of Hims & Hers Health in the 3rd quarter worth about $1,310,000. Finally, Means Investment CO. Inc. bought a new position in shares of Hims & Hers Health in the 3rd quarter worth about $747,000. 63.52% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HIMS has been the topic of a number of recent research reports. Needham & Company LLC raised their price target on shares of Hims & Hers Health from $28.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Bank of America downgraded shares of Hims & Hers Health from a “buy” rating to an “underperform” rating and reduced their price target for the stock from $32.00 to $18.00 in a research report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a research report on Wednesday, November 6th. Morgan Stanley initiated coverage on shares of Hims & Hers Health in a research report on Tuesday, December 17th. They issued an “overweight” rating and a $42.00 price target on the stock. Finally, Canaccord Genuity Group raised their price target on shares of Hims & Hers Health from $28.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, December 2nd. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Hims & Hers Health presently has a consensus rating of “Hold” and a consensus price target of $25.13.

Hims & Hers Health Trading Up 2.1 %

Hims & Hers Health stock opened at $60.41 on Friday. The company’s 50-day moving average price is $32.06 and its two-hundred day moving average price is $24.26. Hims & Hers Health, Inc. has a 52 week low of $9.22 and a 52 week high of $64.84. The stock has a market cap of $13.20 billion, a price-to-earnings ratio of 137.31 and a beta of 1.35.

Insider Buying and Selling

In other news, CFO Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $43.01, for a total value of $498,098.81. Following the transaction, the chief financial officer now directly owns 107,789 shares of the company’s stock, valued at $4,636,004.89. This trade represents a 9.70 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Melissa Baird sold 67,687 shares of Hims & Hers Health stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $44.71, for a total transaction of $3,026,285.77. Following the completion of the transaction, the chief operating officer now directly owns 706,872 shares in the company, valued at approximately $31,604,247.12. This trade represents a 8.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,111,554 shares of company stock worth $33,865,763 in the last ninety days. 17.71% of the stock is currently owned by corporate insiders.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.